Maxcyte

MaxCyte, Inc. is a biotechnology company specializing in cell engineering technology, primarily focusing on advancing cell-based therapies. They generate revenue by providing their proprietary flow electroporation technology to pharmaceutical and biotechnology companies, enabling them to develop and manufacture cell therapies. Founded in 1998, MaxCyte has established itself as a leader in the field, with a strong emphasis on innovation and collaboration. The company's technology is widely used in the development of treatments for cancer and genetic disorders, making it a significant player in the biotech industry.

Recent Posts by Maxcyte

1-14 of 14